CoChat
Cited by 99

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Amyloid beta 42 peptide (Aβ42)-lowering compounds directly bind to Aβ and interfere with amyloid precursor protein (APP) transmembrane dimerization

Richter, Luise, Munter, Lisa-Marie, Ness, Julia, Hildebrand, Peter W., Dasari, Muralidhar, Unterreitmeier, Stephanie, Bulic, Bruno, Beyermann, Michael, Gust, Ronald, Reif, Bernd, Weggen, Sascha, Langosch, Dieter, Multhaup, Gerd · 2010 · Proceedings of the National Academy of Sciences

Abstract

Following ectodomain shedding by β-secretase, successive proteolytic cleavages within the transmembrane sequence (TMS) of the amyloid precursor protein (APP) catalyzed by γ-secretase result in the release of amyloid-β (Aβ) peptides of variable length. Aβ peptides with 42 amino acids appear to be the key pathogenic species in Alzheimer’s disease, as they are believed to initiate neuronal degeneration. Sulindac sulfide, which is known as a potent γ-secretase modulator (GSM), selectively reduces Aβ42 production in favor of shorter Aβ species, such as Aβ38. By studying APP–TMS dimerization we previously showed that an attenuated interaction similarly decreased Aβ42 levels and concomitantly increased Aβ38 levels. However, the precise molecular mechanism by which GSMs modulate Aβ production is still unclear. In this study, using a reporter gene-based dimerization assay, we found that APP–TMS dimers are destabilized by sulindac sulfide and related Aβ42-lowering compounds in a concentration-dependent manner. By surface plasmon resonance analysis and NMR spectroscopy, we show that sulindac sulfide and novel sulindac-derived compounds directly bind to the Aβ sequence. Strikingly, the attenuated APP–TMS interaction by GSMs correlated strongly with Aβ42-lowering activity and binding strength to the Aβ sequence. Molecular docking analyses suggest that certain GSMs bind to the GxxxG dimerization motif in the APP–TMS. We conclude that these GSMs decrease Aβ42 levels by modulating APP–TMS interactions. This effect specifically emphasizes the importance of the dimeric APP–TMS as a promising drug target in Alzheimer’s disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1003026107

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 30

  1. 10.1523/JNEUROSCI.2362-09.2009 · DOI · Paper page
  2. 10.1074/jbc.M109.088005 · DOI · Paper page
  3. 10.1038/sj.emboj.7601616 · DOI · Paper page
  4. 10.1007/s00018-008-7462-2 · DOI · Paper page
  5. 10.1038/nm1235 · DOI · Paper page
  6. 10.1074/jbc.M303592200 · DOI · Paper page
  7. 10.1038/nm1112 · DOI · Paper page
  8. 10.1021/jm00142a016 · doi:10.1021/jm00142a016
  9. 10.1021/jm00142a015 · doi:10.1021/jm00142a015
  10. 10.1016/j.neuropharm.2008.02.009 · DOI
  11. 10.1038/nature07055 · DOI · Paper page
  12. 10.1021/bi901839d · DOI
  13. 10.1006/jmbi.1996.0595 · DOI · Paper page
  14. 10.1016/j.bbrc.2003.10.203 · DOI
  15. 10.1159/000095270 · DOI
  16. 10.1002/anie.200352587 · DOI
  17. 10.1074/jbc.M700618200 · DOI
  18. 10.1074/jbc.M708046200 · DOI
  19. 10.1016/j.molcel.2004.06.037 · DOI
  20. 10.1242/jcs.112.23.4415 · DOI
  21. 10.1074/jbc.M108681200 · DOI · Paper page
  22. 10.1074/jbc.M409430200 · DOI
  23. 10.1074/jbc.M513250200 · DOI
  24. 10.1021/bi901237k · DOI
  25. 10.1002/anie.200353089 · DOI
  26. 10.1021/jm960116z · DOI
  27. 10.1523/JNEUROSCI.1336-09.2009 · DOI
  28. 10.1074/jbc.M303547200 · DOI
  29. M Vaara, The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide. Drugs Exp Clin Res 17, 437–443 (1991).
  30. 10.1097/00001756-199805110-00043 · DOI

Cited by

See all 99

Metadata

Authors
Richter, L., Munter, L.-M., Ness, J., Hildebrand, P. W., Dasari, M., Unterreitmeier, S., Bulic, B., Beyermann, M., Gust, R., Reif, B., Weggen, S., Langosch, D., & Multhaup, G.
Affiliations
  • Institut für Chemie und Biochemie, Freie Universität Berlin, 14195 Berlin, Germany;
  • Institut für Neuropathologie, Heinrich-Heine-Universität, 40225 Düsseldorf, Germany;
  • Institut für Medizinische Physik und Biophysik, Charité, 10117 Berlin, Germany;
  • Leibniz-Institut für Molekulare Pharmakologie, 13125 Berlin, Germany;
  • Lehrstuhl für Chemie der Biopolymere, Technische Universität München, 85354 Freising, Germany;
  • Center for Advanced European Studies and Research, 53175 Bonn, Germany; and
  • Institut für Pharmazie, Freie Universität Berlin, 14195 Berlin, Germany
Venue
Proceedings of the National Academy of Sciences
Published
2010-08-02
Volume
107
Issue
33
Pages
14597-14602
ISSN
  • 0027-8424
  • 1091-6490
Cited by
99
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid beta 42 peptide (Aβ42)-lowering compounds directly bind to Aβ and interfere with amyloid precursor protein (APP) transmembrane dimerization. https://app.cochat.ai/papers/10.1073/pnas.1003026107
The paper
Richter, L., Munter, L.-M., Ness, J., Hildebrand, P. W., Dasari, M., Unterreitmeier, S., Bulic, B., Beyermann, M., Gust, R., Reif, B., Weggen, S., Langosch, D., & Multhaup, G. (2010). Amyloid beta 42 peptide (Aβ42)-lowering compounds directly bind to Aβ and interfere with amyloid precursor protein (APP) transmembrane dimerization. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1003026107

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.